نتائج البحث - "Davide Melisi"

1

Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma

المساهمون: Trestini, I, Paiella, S, Sandini, M, Sperduti, I, Elio, G, Pollini, T, Melisi, D, Auriemma, A, Solda, C, Bonaiuto, C, Tregnago, D, Avancini, A, Secchettin, E, Bonamini, D, Lanza, M, Pilotto, S, Malleo, G, Salvia, R, Bovo, C, Gianotti, L, Bassi, C, Milella, M

المصدر: Annals of Surgical Oncology. 27:5325-5334

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01d204ded54ff3c6fe81f2f92536a68Test
https://doi.org/10.1245/s10434-020-08515-5Test

2

Targeting KRAS: The Elephant in the Room of Epithelial Cancers

المؤلفون: Valeria Merz, Marina Gaule, Camilla Zecchetto, Alessandro Cavaliere, Simona Casalino, Camilla Pesoni, Serena Contarelli, Fabio Sabbadini, Monica Bertolini, Domenico Mangiameli, Michele Milella, Vita Fedele, Davide Melisi

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25b41fab8480d742cf18850bc72549dTest
http://hdl.handle.net/11562/1044674Test

3

Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort

المساهمون: U. Peretti, A. Cavaliere, M. Niger, G. Tortora, M. C. Di Marco, M. G. Rodriquenz, F. Centonze, I. G. Rapposelli, G. Giordano, F. De Vita, L. Stuppia, A. Avallone, M. Ratti, C. Paratore, L. G. Forti, G. Orsi, M. M. Valente, M. Gaule, M. Macchini, P. Carrera, S. Calzavara, M. Simbolo, D. Melisi, F. De Braud, L. Salvatore, S. De Lorenzo, C. Chiarazzo, M. Falconi, S. Cascinu, M. Milella, M. Reni, Peretti, U, Cavaliere, A, Niger, M, Tortora, G, Di Marco, M C, Rodriquenz, M G, Centonze, F, Rapposelli, I G, Giordano, G, De Vita, F, Stuppia, L, Avallone, A, Ratti, M, Paratore, C, Forti, L G, Orsi, G, Valente, M M, Gaule, M, Macchini, M, Carrera, P, Calzavara, S, Simbolo, M, Melisi, D, De Braud, F, Salvatore, L, De Lorenzo, S, Chiarazzo, C, Falconi, M, Cascinu, S, Milella, M, Reni, M, Peretti, U., Cavaliere, A., Niger, M., Tortora, G., Di Marco, M. C., Rodriquenz, M. G., Centonze, F., Rapposelli, I. G., Giordano, G., De Vita, F., Stuppia, L., Avallone, A., Ratti, M., Paratore, C., Forti, L. G., Orsi, G., Valente, M. M., Gaule, M., Macchini, M., Carrera, P., Calzavara, S., Simbolo, M., Melisi, D., De Braud, F., Salvatore, L., De Lorenzo, S., Chiarazzo, C., Falconi, M., Cascinu, S., Milella, M., Reni, M.

المصدر: ESMO Open

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc764c9bb54985c2b23cccd2af443024Test
https://pubmed.ncbi.nlm.nih.gov/33399070Test

4

First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study

المؤلفون: C. Benedikt Westphalen, Gerald W. Prager, Julien Taieb, A. Ferreras, Teresa Macarulla, Alfredo Carrato, Davide Melisi, Nathalie D'Esquermes

المساهمون: Institut Català de la Salut, [Taieb J] Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Sorbonne Paris Cité, Université Paris Descartes, Paris, France. [Prager GW] Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. [Melisi D] Digestive Molecular Clinical Oncology Research Unit, Department of Medicine, Università degli Studi di Verona, Verona, Veneto, Italy. [Westphalen CB] Department of Medicine III and Comprehensive Cancer Center Munich, University Hospital LMU Munich, Munich, Germany. [D'Esquermes N, Ferreras A] Genactis SAS, Mougins, France. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: ESMO Open
Scientia

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, FOLFIRINOX, Population, pancreatic cancer, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Western Europe, Adenocarcinoma, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Internal medicine, Pancreatic cancer, medicine, Humans, 5-fluorouracil, albumin-bound paclitaxel, gemcitabine, Neoplasm Metastasis, education, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], Reimbursement, Original Research, Retrospective Studies, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], education.field_of_study, Pàncrees - Càncer - Quimioteràpia, business.industry, Adenocarcinoma - Quimioteràpia, Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma [DISEASES], neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::adenocarcinoma [ENFERMEDADES], Middle Aged, medicine.disease, Gemcitabine, Oxaliplatin, Irinotecan, Europe, Pancreatic Neoplasms, Oncology, Observational study, Female, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47f0a272bb4d6dc753495e756e6b9cdTest
http://europepmc.org/articles/PMC7003396Test

5

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis

المؤلفون: Li-Tzong Chen, Uwe Pelzer, Jens T. Siveke, Davide Melisi, Jean-Frédéric Blanc, Andrea Wang-Gillam, Caitlyn T. Solem, Yin Wan, Floris A. de Jong, Antonio Cubillo, Richard A Hubner, Marc F. Botteman, Daniel D. Von Hoff, Yoojung Yang

المصدر: British Journal of Cancer

مصطلحات موضوعية: Male, Oncology, Cancer Research, pancreatic cancer, Leucovorin, Deoxycytidine, Gastroenterology, chemistry.chemical_compound, 0302 clinical medicine, metastatic pancreatic cancer, Antineoplastic Combined Chemotherapy Protocols, 030212 general & internal medicine, Aged, 80 and over, clinical trial, Middle Aged, Survival Rate, Fluorouracil, 030220 oncology & carcinogenesis, Retreatment, Toxicity, Disease Progression, Female, medicine.drug, Adult, medicine.medical_specialty, Adenocarcinoma, Irinotecan, Disease-Free Survival, 03 medical and health sciences, Internal medicine, Pancreatic cancer, medicine, Humans, Lung cancer, Survival rate, NAPOLI-1, Aged, business.industry, medicine.disease, Gemcitabine, Pancreatic Neoplasms, chemistry, Liposomes, Quality of Life, Clinical Study, Nanoparticles, Camptothecin, business, Q-TWiST

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02016c44c20de62b40be7f5509bb0226Test
https://doi.org/10.1038/bjc.2017.67Test

6

Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma

المساهمون: Mottini, C, Tomihara, H, Carrella, D, Lamolinara, A, Iezzi, M, Huang, Jk, Amoreo, Ca, Buglioni, S, Manni, I, Robinson, F, Minelli, R, Kang, Y, Fleming, Jb, Kim, Mp, Bristow, Ca, Trisciuoglio, D, Iuliano, A, Del Bufalo, D, Di Bernardo, D, Melisi, D, Draetta, Gf, Ciliberto, G, Carugo, A, Cardone, L.

المصدر: Cancer research (Chic. Ill.) 79 (2019): 5612–5625. doi:10.1158/0008-5472.CAN-19-0187
info:cnr-pdr/source/autori:Mottini C.; Tomihara H.; Carrella D.; Lamolinara A.; Iezzi M.; Huang J.K.; Amoreo C.A.; Buglioni S.; Manni I.; Robinson F.S.; Minelli R.; Kang Y.; Fleming J.B.; Kim M.P.; Bristow C.A.; Trisciuoglio D.; Iuliano A.; Bufalo D.D.; Bernardo D.D.; Melisi D.; Draetta G.F.; Ciliberto G.; Carugo A.; Cardone L./titolo:Predictive signatures inform the effective repurposing of decitabine to treat KRAS-dependent pancreatic ductal adenocarcinoma/doi:10.1158%2F0008-5472.CAN-19-0187/rivista:Cancer research (Chic. Ill.)/anno:2019/pagina_da:5612/pagina_a:5625/intervallo_pagine:5612–5625/volume:79

مصطلحات موضوعية: 0301 basic medicine, Drug, Cancer Research, endocrine system diseases, media_common.quotation_subject, pancreatic cancer, Decitabine, Mice, SCID, Adenocarcinoma, medicine.disease_cause, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Mice, 0302 clinical medicine, Mice, Inbred NOD, Pancreatic cancer, Cell Line, Tumor, KRAS, medicine, Carcinoma, Animals, Humans, neoplasms, Protein Kinase Inhibitors, Repurposing, media_common, business.industry, Drug Repositioning, Gene signature, medicine.disease, digestive system diseases, respiratory tract diseases, Pancreatic Neoplasms, 030104 developmental biology, Pyrimidines, Oncology, 030220 oncology & carcinogenesis, Cancer cell, Mutation, Cancer research, business, medicine.drug, Carcinoma, Pancreatic Ductal, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1484d925ac0b7cbce7ee14d6edda8fTest
https://pubmed.ncbi.nlm.nih.gov/31492820Test

7

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

المؤلفون: Maria Bencivenga, Carmine Carbone, G. De Manzoni, Geny Piro, Davide Melisi, Maria Mihaela Mina, Marco Zanotto, Giampaolo Tortora, Melissa Frizziero, Valeria Merz, Raffaela Santoro, S. Giacopuzzi, Giuseppe Verlato, Andrea Zanoni

المصدر: British Journal of Cancer

مصطلحات موضوعية: Male, Oncology, Cancer Research, Esophageal Neoplasms, Colorectal cancer, Apoptosis, Docetaxel, Radiation Tolerance, chemoradiotherapy, Inhibitor of Apoptosis Proteins, Antineoplastic Combined Chemotherapy Protocols, oesophageal carcinoma, chemoradiotherapy, BIRC3 expression, BIRC3, Middle Aged, MAP Kinase Kinase Kinases, Baculoviral IAP Repeat-Containing 3 Protein, Neoplasm Proteins, oesophageal carcinoma, Carcinoma, Squamous Cell, Zearalenone, Adenocarcinoma, Female, Taxoids, Esophagogastric Junction, Fluorouracil, Liver cancer, medicine.drug, medicine.medical_specialty, TAK1, Ubiquitin-Protein Ligases, Down-Regulation, In Vitro Techniques, resistance, Cell Line, Tumor, Internal medicine, medicine, Carcinoma, Humans, RNA, Messenger, Kinase activity, Lung cancer, Aged, business.industry, BIRC3 expression, medicine.disease, ROC Curve, Drug Resistance, Neoplasm, Cancer research, oesophageal adenocarcinoma, Cisplatin, Translational Therapeutics, business, Chemoradiotherapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac936b31fc9542dabd5b6ea7da1d1b9Test
https://doi.org/10.1038/bjc.2015.283Test

8

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

المصدر: JAMA Surgery. 154:932

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360db016155ac34fae517edb1c2fa553Test
https://doi.org/10.1001/jamasurg.2019.2277Test

9

CT texture analysis of ductal adenocarcinoma downstaged after chemotherapy

المؤلفون: Paola Capelli, Giovanni Marchegiani, Roberto Salvia, Valentina Ciaravino, Mirko D'Onofrio, Davide Melisi, Francesca Simionato, Nicolò Cardobi, Riccardo De Robertis

مصطلحات موضوعية: Male, neoadjuvant treatment, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, pancreatic cancer, pancreatic ductal adenocarcinoma, Adenocarcinoma, downstaged adenocarcinoma, Disease-Free Survival, 030218 nuclear medicine & medical imaging, texture analysis, 03 medical and health sciences, 0302 clinical medicine, Neoadjuvant treatment, Pancreatic cancer, medicine, Humans, Ductal adenocarcinoma, Stage (cooking), Pancreas, Aged, Neoplasm Staging, Retrospective Studies, Chemotherapy, business.industry, Disease progression, Significant difference, General Medicine, Middle Aged, medicine.disease, Combined Modality Therapy, Neoadjuvant Therapy, Pancreatic Neoplasms, Oncology, 030220 oncology & carcinogenesis, Female, Radiology, business, Tomography, X-Ray Computed, After treatment, Carcinoma, Pancreatic Ductal

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f002cd1adacbe8e97d1a1876f67c758dTest
https://hdl.handle.net/11577/3476825Test

10

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling

المؤلفون: Carmine Carbone, Francesca Ligorio, F. Di Nicolantonio, Aldo Scarpa, Paul Takam Kamga, G Conti, L De Franceschi, Francesca Simionato, Davide Melisi, Geny Piro, Giampaolo Tortora, Nicola Gaianigo, Camilla Zecchetto, Valeria Merz, Mauro Krampera, Geppino Falco, Raffaela Santoro

المساهمون: Carbone, C, Piro, G, Gaianigo, N, Ligorio, F, Santoro, R, Merz, V, Simionato, F, Zecchetto, C, Falco, G, Conti, G, Kamga, P T, Krampera, M, Di Nicolantonio, F, De Franceschi, L, Scarpa, A, Tortora, G, Melisi, D

المصدر: International Journal of Obesity (2005)

مصطلحات موضوعية: 0301 basic medicine, EXPRESSION, medicine.medical_specialty, Frizzled, Epithelial-Mesenchymal Transition, Endocrinology, Diabetes and Metabolism, adipocytes, pancreatic cancer, Medicine (miscellaneous), Receptor tyrosine kinase-like orphan receptor, MICROENVIRONMENT, Biology, Receptor Tyrosine Kinase-like Orphan Receptors, pancreatic cancer, epithelial-to-mesenchymal transition, adipocytes, Models, Biological, THERAPY, Cell Line, 03 medical and health sciences, Paracrine signalling, 0302 clinical medicine, Internal medicine, Pancreatic cancer, medicine, Humans, Epithelial–mesenchymal transition, RSPO1, BODY-MASS INDEX, STEM-CELLS, OBESITY, RESISTANCE, RISK, ADENOCARCINOMA, METAANALYSIS, Cell Nucleus, Nutrition and Dietetics, Wnt signaling pathway, Mesenchymal Stem Cells, medicine.disease, Pancreatic Neoplasms, Wnt Proteins, 030104 developmental biology, Endocrinology, Adipogenesis, 030220 oncology & carcinogenesis, Cancer research, Original Article, epithelial-to-mesenchymal transition, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69fd194b6b6e0fdfa271697b311f840cTest
http://hdl.handle.net/11562/970435Test

تنقيح النتائج